NEWS COMMENTARY

Abbott plans to develop a line of consumer wearables, pushing deeper into consumer health and nutrition

Published:
January 14, 2022
Last Updated:
January 14, 2022
Services:
CPG More...
Priorities:
Consumer Health and Wellness More...
Activities:
Product
Very important

Abbott announced its plans to develop a new category of consumer wearables called Lingo at CES 2022. Lingo aims to measure biomarkers such as glucose, ketones, and lactates, which provide insights into physiological conditions like ketosis and lactate buildup after exercise. This announcement closely follows the release of Abbott's FreeStyle Libre minimally invasive continuous glucose monitor, which was introduced for diabetics, with a separate product line tailored to athletes in 2020. Using Lux's health spectrum model, we forecasted healthcare companies tapping into opportunities further up the wellness space. Clients should expect to see more developments from Abbott and other players expanding into personalized nutrition and wellness.

For the original news article, click here .


Further Reading

Neteera Technologies

Company Snapshot | December 07, 2021

The company was started by Haim Goldberger and Isaac Litman in 2014. To date, the company has raised about $8.5 million over two seed rounds, the latest being a $6.5 million seed round in December 2017. Among its investors, we emphasize Plug and Play Tech Center and Q Venture Partners. The company ... To read more, click here.

Royal Philips begins clinical trials for first at-home ECG solution

News Commentary | February 07, 2022

Philips' device will be the industry's first attempt at an at‑home, 12‑lead ECG (electrocardiogram). It will include access to Philips' cardiac monitoring portfolio, which pairs cloud‑based data collection with data readings it claims are comparable to clinical ECGs. While the solution is still in ... Not part of subscription

Glooko

Company Profile | May 13, 2022

Glooko's mobile health app and cloud‑based diabetes management system enables patients to upload self‑monitored diabetes data to the cloud and share it with their care team The biggest contributor to patient empowerment is the ability to correlate lifestyle events (diet, exercise, medications) ... Not part of subscription